Albendazole has been used successfully in the treatment of cerebral cy
sticercosis for several years. The published dosage schedule has varie
d from 15 mg/kg/day for 8 days to up to 30 days. Fifty three patients
with neurocysticercosis received 8, 15 or 30 days treatment with 800 m
g of albendazole daily. The present study demonstrates the effectivene
ss in clinical and radiological terms of albendazole 800 mg/day for 8
days for the majority of patients affected with cystic or encephalitic
parenchymatous cysticercosis. There was no apparent advantage of cont
inuation of treatment for 15 or 30 days in this series. The routine us
e of high dose steroids limited the effects of parasite destruction. N
o toxicity attributable to albendazole was encountered.